A. Sibille

Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications.

C. Eng, G. Grabowski, G. Pastores, 1993, American journal of human genetics.

Three colleagues with sarcoidosis?

W. Wuyts, P. van Bleyenbergh, K. Lagrou, 2011, European Respiratory Journal.

Enzyme therapy in Gaucher disease type 1: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 months.

G. Grabowski, G. Pastores, A. Sibille, 1993, Blood.

Enzyme Augmentation in Moderate to Life-Threatening Gaucher Disease

G. Hermann, R. Shapiro, S. Fallet, 1992, Pediatric Research.